Skip to main content
OpenTrials

Clinical trial condition

Bile Duct Diseases

Explore clinical trials studying Bile Duct Diseases. Study availability and eligibility vary by location and protocol.

667 public trials 130 recruiting studies
Refine in advanced search Browse all conditions

Bile Duct Diseases trial results

Active, Not Recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health Chandler, Arizona, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 115 locations
View Trial Details
Active, Not Recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

NCT05035030

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • UCSF San Francisco, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Riley Hospital for Children at IU Health Indianapolis, Indiana, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Linerixibat Long-term Safety, and Tolerability Study

NCT04167358

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site West Hollywood, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Detroit, Michigan, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

NCT05627362

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Om Research LLC Lancaster, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • Sutter Health Van Ness Campus Medical Office Building San Francisco, California, United States
View all 62 locations
View Trial Details
Active, Not Recruiting

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

NCT04042831

Conditions
Bile Duct Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +9 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions